ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

FEMHRT 0.5/2.5
Menopause and HRT
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

FEMHRT 0.5/2.5 Rx

Generic Name and Formulations:
Norethindrone acetate 0.5mg, ethinyl estradiol 2.5mcg; tabs.

Company:
Allergan

Therapeutic Use:

Indications for FEMHRT 0.5/2.5:

In women with an intact uterus: moderate to severe vasomotor symptoms associated with menopause; osteoporosis prevention.

Adult:

1 tab daily. Reevaluate periodically.

Children:

Not applicable.

Contraindications:

Breast or estrogen-dependent carcinoma. Undiagnosed abnormal genital bleeding. Thrombophlebitis. Thromboembolic disorders. Missed abortion. Pregnancy (Cat.X).

Warnings/Precautions:

Gallbladder disease. Hypercalcemia in breast cancer or bone metastases. Conditions aggravated by fluid retention. Hepatic impairment. Hypercoagulability. Familial hyperlipoproteinemia. Depression. Do initial complete physical exam and repeat at least yearly (include BP, PAP smear, mammogram). Discontinue if cardiovascular events, jaundice, visual abnormalities or migraine occurs and at least 2 weeks before surgery associated with increased risk of thromboembolism. Nursing mothers.

Interactions:

May be antagonized by rifampin, troglitazone, anticonvulsants. May antagonize temazepam, morphine, clofibrate. May be potentiated by Vit. C, acetaminophen, atorvastatin. Monitor theophylline, cyclosporine. May interfere with lab tests; see literature.

See Also:

FEMHRT 1/5

Pharmacological Class:

Progestin + estrogen.

Adverse Reactions:

GI upset, constipation, headache, edema, depression, nervousness, mastodynia, intolerance to contact lenses, glucose intolerance, changes in serum lipids; others.

How Supplied:

Tabs—28, 90

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs